CAS: 166089-32-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lintuzumab REF: TM-T9901A-065CAS: 166089-32-3 | ≥95% (SDS-PAGE/SEC-HPLC) - ≥95% (SDS-PAGE/SEC-HPLC) | 198.00 €~1,476.00 € | Wed 08 Jan 25 |
 | Lintuzumab REF: 3D-CLA1066CAS: 166089-32-3 | - - - | To inquire | Tue 21 Jan 25 |
Lintuzumab
CAS:166089-32-3
Lintuzumab (HuM-195) is an uncoupled humanized mouse monoclonal antibody against CD33 with anti-leukemic activity.
Purity:
≥95% (SDS-PAGE/SEC-HPLC) - ≥95% (SDS-PAGE/SEC-HPLC)
Color and Shape:
Liquid
Ref: TM-T9901A-065
| 1mg | 198.00 € | ||
| 5mg | 489.00 € | ||
| 10mg | 686.00 € | ||
| 25mg | 1,070.00 € | ||
| 50mg | 1,476.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: 3D-CLA1066
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
